SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-206902
Filing Date
2023-08-09
Accepted
2023-08-09 09:47:55
Documents
1
Effectiveness Date
2023-08-09

Document Format Files

Seq Description Document Type Size
1 S-8 POS d539640ds8pos.htm S-8 POS 20066
  Complete submission text file 0001193125-23-206902.txt   21319
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: S-8 POS | Act: 33 | File No.: 333-270563 | Film No.: 231153688
SIC: 2834 Pharmaceutical Preparations